Press Center

The new review of the most notable patents disputes in Life Sciences in EAEU and CIS.

• pdf, 5.00 Mb

Vladislav Ryabov has been a member of the Lidings team since 2021. Over this time, he has established himself as one of the firm's leading experts in intellectual property protection. In his new role as Counsel, Vladislav will focus on further developing the firm's litigation practice in complex disputes concerning trademarks, patents, and unfair competition, strengthening Lidings' position in the IP market.

From 1 September 2026, new rules for calculating remuneration for employees who are the authors of employee inventions, utility models and industrial designs will come into force. The document fundamentally changes the approach to such payments.

The Russian Ministry of Health’s draft law “On Amending Certain Legislative Acts of the Russian Federation…” (“the Draft Law”), concerning changes to the control of the circulation of medicinal products has been published on the federal portal for draft regulatory acts.

The Lidings team, led by Managing Partner Boris Malakhov and including Senior Associate Vladislav Ryabov, Associate Ivan Vasiliev, and Junior Associate Alena Troitskaya, advised the client in the dispute concerning intellectual property and brand protection in the Russian Federation.

The new review of the most notable patents disputes in Life Sciences in EAEU and CIS.

• pdf, 13.31 Mb

Lidings takes high positions in the new rating of the leading legal advisors in Russia based on the analytical research held annually by the “Kommersant” newspaper. In 2026 the firm is ranked among the TOP leading legal advisors in Russia. 

April 9^th,2026 annual conference Pharmaceuticals – 2026: Legal Issues will take place in Moscow organized by Pravo.ru. Lidings lawyers take an active part in the event’s program.

As a strategic partner of the conference, we aimed to make the program rich and actual. Together with pharmaceutical industry experts and lawyers, we will discuss how the market has changed in 2025 and what awaits us in 2026.